Publication: Effect of on-demand vs routine nebulization of acetylcysteine with salbutamol on ventilator-free days in intensive care unit patients receiving invasive ventilation: A randomized clinical trial
3
Issued Date
2018-03-13
Resource Type
ISSN
15383598
00987484
00987484
Other identifier(s)
2-s2.0-85043571032
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
JAMA - Journal of the American Medical Association. Vol.319, No.10 (2018), 993-1001
Suggested Citation
David M.P. Van Meenen, Sophia M. Van Der Hoeven, Jan M. Binnekade, Corianne A.J.M. De Borgie, Maruschka P. Merkus, Frank H. Bosch, Henrik Endeman, Jasper J. Haringman, Nardo J.M. Van Der Meer, Hazra S. Moeniralam, Mathilde Slabbekoorn, Marcella C.A. Muller, Willemke Stilma, Bart Van Silfhout, Ary Serpa Neto, Hans F.M. Ter Haar, Jan Van Vliet, Jan Willem Wijnhoven, Janneke Horn, Nicole P. Juffermans, Paolo Pelosi, Marcelo Gama De Abreu, Marcus J. Schultz, Frederique Paulus Effect of on-demand vs routine nebulization of acetylcysteine with salbutamol on ventilator-free days in intensive care unit patients receiving invasive ventilation: A randomized clinical trial. JAMA - Journal of the American Medical Association. Vol.319, No.10 (2018), 993-1001. doi:10.1001/jama.2018.0949 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/46829
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Effect of on-demand vs routine nebulization of acetylcysteine with salbutamol on ventilator-free days in intensive care unit patients receiving invasive ventilation: A randomized clinical trial
Author(s)
David M.P. Van Meenen
Sophia M. Van Der Hoeven
Jan M. Binnekade
Corianne A.J.M. De Borgie
Maruschka P. Merkus
Frank H. Bosch
Henrik Endeman
Jasper J. Haringman
Nardo J.M. Van Der Meer
Hazra S. Moeniralam
Mathilde Slabbekoorn
Marcella C.A. Muller
Willemke Stilma
Bart Van Silfhout
Ary Serpa Neto
Hans F.M. Ter Haar
Jan Van Vliet
Jan Willem Wijnhoven
Janneke Horn
Nicole P. Juffermans
Paolo Pelosi
Marcelo Gama De Abreu
Marcus J. Schultz
Frederique Paulus
Sophia M. Van Der Hoeven
Jan M. Binnekade
Corianne A.J.M. De Borgie
Maruschka P. Merkus
Frank H. Bosch
Henrik Endeman
Jasper J. Haringman
Nardo J.M. Van Der Meer
Hazra S. Moeniralam
Mathilde Slabbekoorn
Marcella C.A. Muller
Willemke Stilma
Bart Van Silfhout
Ary Serpa Neto
Hans F.M. Ter Haar
Jan Van Vliet
Jan Willem Wijnhoven
Janneke Horn
Nicole P. Juffermans
Paolo Pelosi
Marcelo Gama De Abreu
Marcus J. Schultz
Frederique Paulus
Other Contributor(s)
Ospedale Policlinico San Martino
Amphia Hospital
St. Antonius Ziekenhuis
Dresden University Faculty of Medicine and University Hospital Carl Gustav Carus
Our Lady Hospital - Amsterdam
Hospital Israelita Albert Einstein
Mahidol University
Isala Clinics
Amsterdam UMC - University of Amsterdam
Haaglanden Medical Center
Amphia Hospital
St. Antonius Ziekenhuis
Dresden University Faculty of Medicine and University Hospital Carl Gustav Carus
Our Lady Hospital - Amsterdam
Hospital Israelita Albert Einstein
Mahidol University
Isala Clinics
Amsterdam UMC - University of Amsterdam
Haaglanden Medical Center
Abstract
© 2018 American Medical Association. All rights reserved. IMPORTANCE: It remains uncertain whether nebulization of mucolytics with bronchodilators should be applied for clinical indication or preventively in intensive care unit (ICU) patients receiving invasive ventilation. OBJECTIVE: To determine if a strategy that uses nebulization for clinical indication (on-demand) is noninferior to one that uses preventive (routine) nebulization. DESIGN, SETTING, AND PARTICIPANTS: Randomized clinical trial enrolling adult patients expected to need invasive ventilation for more than 24 hours at 7 ICUs in the Netherlands. INTERVENTIONS: On-demand nebulization of acetylcysteine or salbutamol (based on strict clinical indications, n = 471) or routine nebulization of acetylcysteine with salbutamol (every 6 hours until end of invasive ventilation, n = 473). MAIN OUTCOMES AND MEASURES: The primary outcome was the number of ventilator-free days at day 28, with a noninferiority margin for a difference between groups of -0.5 days. Secondary outcomes included length of stay, mortality rates, occurrence of pulmonary complications, and adverse events. RESULTS: Nine hundred twenty-two patients (34% women; median age, 66 (interquartile range [IQR], 54-75 years) were enrolled and completed follow-up. At 28 days, patients in the on-demand group had a median 21 (IQR, 0-26) ventilator-free days, and patients in the routine group had a median 20 (IQR, 0-26) ventilator-free days (1-sided 95% CI, -0.00003 to ∞). There was no significant difference in length of stay or mortality, or in the proportion of patients developing pulmonary complications, between the 2 groups. Adverse events (13.8% vs 29.3%; difference, -15.5% [95% CI, -20.7% to -10.3%]; P <.001) were more frequent with routine nebulization and mainly related to tachyarrhythmia (12.5% vs 25.9%; difference, -13.4% [95% CI, -18.4% to -8.4%]; P <.001) and agitation (0.2% vs 4.3%; difference, -4.1% [95% CI, -5.9% to -2.2%]; P <.001). CONCLUSIONS AND RELEVANCE: Among ICU patients receiving invasive ventilation who were expected to not be extubated within 24 hours, on-demand compared with routine nebulization of acetylcysteine with salbutamol did not result in an inferior number of ventilator-free days. On-demand nebulization may be a reasonable alternative to routine nebulization.
